ARKG vs SCHA
ARK Genomic Revolution ETF vs Schwab US Small-Cap ETF
ARKG$47.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
SCHA$33.55
Schwab US Small-Cap ETF
US small-cap equities.
Expense: 0.03%Yield: 1.12%
Quick take
- • SCHA has the lower expense ratio at 0.03% vs 0.75% for ARKG.
- • SCHA pays a higher dividend yield (1.12%).
Side-by-side metrics
| Metric | ARKG | SCHA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.03% |
Dividend yield Trailing 12-month yield. | 0.00% | 1.12% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $22.04B |
YTD return | 66.55% | 18.09% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 1.23 |
P/E ratio | — | 16.37 |
Last price | $47.17 | $33.55 |
Inception | — | — |
Issuer | ARK | Schwab |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
Sector breakdown · ARKG
Healthcare100.0%
SCHA top holdings
Top holdings · SCHA
| HALO | Halozyme Therapeutics Inc | 0.36% |
| GKOS | Glaukos Corp | 0.34% |
| W | Wayfair Inc Class A | 0.32% |
| BMNR | BitMine Immersion Technologies Inc | 0.29% |
| AHR | American Healthcare REIT Inc Ordinary Shares | 0.28% |
| BTSG | BrightSpring Health Services Inc | 0.27% |
| R | Ryder System Inc | 0.26% |
| VSAT | Viasat Inc | 0.26% |
| ENSG | Ensign Group Inc | 0.25% |
| WTFC | Wintrust Financial Corp | 0.25% |
Sector breakdown · SCHA
Real Estate6.9%
Consumer Cyclical11.1%
Basic Materials4.2%
Consumer Defensive2.9%
Technology15.1%
Communication Services2.8%
Financial Services16.9%
Utilities2.5%
Industrials14.5%
Energy5.8%
Healthcare17.3%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SCHA
SCHA (Schwab US Small-Cap ETF) is US small-cap equities. Managed by Schwab, the fund carries $22.0B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.12%. Its largest holding is Halozyme Therapeutics Inc (HALO), which represents 0.4% of the portfolio. Real Estate is the fund's largest sector exposure at 6.9%.